Patents
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
01/2001
01/30/2001US6180675 IL-8 receptor antagonists
01/30/2001US6180654 Heterocyclic nonnucleoside inhibitors of reverse transcriptase
01/30/2001US6180650 Antiinflammatory agents; respiratory system disorders; skin disorders; antitumor agents
01/30/2001US6180623 Used as analgesics and anti-pruritic agents
01/30/2001US6179881 Compositions and processes for dyeing keratin fibers with azo compounds
01/30/2001CA2026360C Control of isomer distribution in a chlorination process
01/30/2001CA1341173C Fungicides
01/25/2001WO2001005769A2 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation
01/25/2001WO2001005768A1 Tricyclic compounds bearing acyloxymethoxycarbonyl pendants
01/25/2001WO2001005767A1 Organic compounds
01/25/2001WO2001005766A2 Process for the preparation of 3,5-dichloropyridine
01/25/2001WO2001005763A2 Compounds with activity on muscarinic receptors
01/25/2001WO2001005756A1 3-arylsulfonyl-2-(substituted methyl)propanoic acid derivates as matrix metalloproteinase inhibitors
01/25/2001WO2001005753A1 Diacylhydrazine derivatives
01/25/2001WO2001005398A1 Phosphate transport inhibitors
01/25/2001WO2001005392A2 Method for treating chronic pain using mek inhibitors
01/25/2001WO2000066550A8 New compounds
01/25/2001WO2000058293A3 Glucokinase activators
01/25/2001WO2000044740A3 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
01/25/2001DE19934394A1 New N-phenylnaphthalenesulfonamide derivatives useful for treatment and prevention of viral infection, especially cytomegalovirus
01/25/2001DE19934321A1 New N-phenyl-naphthalenesulfonamide derivatives are antiviral agents especially useful for treating cytomegalovirus infections
01/25/2001DE19922392C1 Diaminobenzol-Derivate und diese Verbindungen enthaltende Färbemittel Diaminobenzene derivatives and compounds containing colorants
01/25/2001CA2379657A1 Phosphate transport inhibitors
01/25/2001CA2379041A1 Diacylhydrazine derivatives
01/25/2001CA2375909A1 Tricyclic compounds bearing acyloxymethoxycarbonyl pendants
01/25/2001CA2374052A1 Method for treating chronic pain using mek inhibitors
01/24/2001EP1070703A1 Cyclobutene derivatives
01/24/2001EP1070060A1 Heterocyclic glycyl beta-alanine derivatives as vitronectin antagonists
01/24/2001EP1070053A1 Synthesis of 3-amino-2-chloro-4-methylpyridine from acetone and ethyl cyanoacetate
01/24/2001EP1070052A1 Fungicide compositions comprising a hydroximic or hydrazonic group
01/24/2001EP1070049A1 Benzamide and sulfonamide substituted aminoguanidines and alkoxyguanidines as protease inhibitors
01/24/2001EP1070046A1 Propanolamine derivatives
01/24/2001EP1070041A1 Phosphate-mediated cyclization
01/24/2001EP1069901A1 Calcilytic compounds and method of use
01/24/2001EP1069898A1 Topical antiseptic compositions and methods
01/24/2001EP0821673B1 New form of (e)-3- 6- (2,6-dichlorophenyl)-thio]methyl]-3-(2-phenylethoxy)-2-pyridinyl]-2-propenoic acid
01/24/2001CN1281438A Piperazine compounds and medical use thereof
01/24/2001CN1281437A Method for producing isoureas
01/24/2001CN1281436A N-Benzyl-3-indenylacetamides derivatives for treating neoplasia
01/24/2001CN1281430A N-alkanoylphenylalanine derivatives
01/24/2001CN1281426A Apoptosis inducer
01/23/2001US6177588 Having retinoid-like, retinoid antagonist or retinoid inverse agonist-like bioactivity; side effect reduction; skin disorders; antiproliferative and -carcinogenic agents; microbiocides; vision defects; cardiovascular disorders
01/23/2001US6177466 Matrix metalloproteinase inhibitors
01/23/2001US6177463 Oxime derivatives and their use as pesticides
01/23/2001US6177462 Unsaturated oxime ethers and their use as fungicides and insecticides
01/23/2001US6177459 Substituted heterocyclic compounds and their use as fungicides
01/23/2001US6177448 Therapy for chemokine sensitivie disease
01/23/2001US6177428 Treatment of sexual dysfunction; stimulation of endogenous nitrogen monoxide synthesis
01/23/2001US6177419 Antioxidant chelate compounds for preventing oxygen free radical-associated diseases in mammals; neuroprotectants, superoxide dismutase (sod), catalase (cat) and/or peroxidase (pod) mimetics
01/23/2001US6177409 Method for the site specific synthesis of novel 3-hydroxypyridin-4(1H)ons derivatives from aminomonosaccharides or aminoitols, products obtained by this method and their applications
01/23/2001US6177154 Miscibility; low in threshold voltage, induce large pretilt angle, high in voltage holding ratio and are low in its dependency on temperature
01/22/2001CA2312203A1 Cyclobutene derivatives, their preparation and their therapeutic uses
01/18/2001WO2001004117A1 Heteroaryl protease inhibitors and diagnostic imaging agents
01/18/2001WO2001004115A2 Novel process for synthesis of heteroaryl-substituted urea compounds
01/18/2001WO2001004097A2 Cyclic delocalized cations connected by spacer groups
01/18/2001WO2001004087A1 Sulfonamide substituted benzylamine derivatives and their use as medicaments
01/18/2001WO2000068190A3 1-alkoxy and 1-acyloxy substituted cyclohex-1-ene compounds and sulfur and 1-alkoxycarbonyl analogs having retinoid-like biological activity
01/18/2001DE19932796A1 Diacylhydrazinderivate Diacylhydrazinderivate
01/18/2001DE19930960A1 Verfahren zur Oxidation von organischen Verbindungen A process for the oxidation of organic compounds
01/18/2001CA2379416A1 Heteroaryl protease inhibitors and diagnostic imaging agents
01/17/2001EP1069112A1 N-(phenylsulfonyl) picolinamide derivatives, process for producing the same, and herbicide
01/17/2001EP1069108A1 Process for producing aromatic and heterocyclic nitriles
01/17/2001EP1068304A1 Treatment of parasitic diseases by inhibition of cysteine proteases of the papain superfamily
01/17/2001EP1068203A1 Process for the preparation of nitroguanidine derivatives
01/17/2001EP1068196A1 Nitrate salt of anti-ulcer medicine
01/17/2001EP1068186A2 Pharmaceutical compositions and methods for use
01/17/2001EP1068178A1 NON-PEPTIDE GnRH AGENTS
01/17/2001EP1067894A2 Protease inhibitors
01/17/2001EP0983258A4 N-hydroxy 4-sulfonyl butanamide compounds
01/17/2001EP0912502B1 2-chloro-3,5-bis(trifluoromethyl)phenyl benzoyl urea derivative and process for preparing the same
01/17/2001EP0725059B1 2,3-diaminopropionic acid derivative
01/17/2001CN1280568A Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors
01/17/2001CN1280561A Amidocarboxylic acid derivatives
01/17/2001CN1280560A Adamantane derivatives
01/17/2001CN1060615C Guanidine derivatives insecticides composition
01/16/2001US6175018 Process for preparation of propionic acid derivatives
01/16/2001US6175016 Such as 3-hydroxy-1-(5-amino-5-carboxy-pentyl)-4-(1-amino-1-carboxy-2-ethyl)-5-(3 -amino-3-carboxy-propyl) pyridinium hydrochloride; making via cyclization reaction; for use in diagnosing bone and connective tissue disorders
01/16/2001US6175012 Processes and intermediates for the preparation of piperazine derivatives
01/16/2001US6175011 Preparing aryloxy arylamides of pyridine-, pyrimidine-, pyrazine- and 1,3,5-triazine-carboxylic acids by reacting the heteroaromatic dihalide with an aromatic hydroxy then with carbon monoxide and an arylamine using diphosphine catalyst
01/16/2001US6174922 Sulphonamide derivatives
01/16/2001US6174905 As carcinostatic agent to a hematologic malignancy and a solid carcinoma
01/16/2001US6174901 For treatment of rheumatoid arthritis, pagets disease, osteophorosis, multiple myeloma, uveititis, acute or chronic myelogenous leukemia, pancreatic .beta. cell destruction, osteoarthritis, rheumatoid spondylitis, gouty arthritis etc.
01/16/2001US6174887 Amide compounds and use of the same
01/16/2001US6174457 Compound having alkadienyl group as side chain, and liquid crystal composition using same
01/11/2001WO2001002596A1 Method for oxidating organic compounds
01/11/2001WO2001002376A1 Amino-alkyl derivatives
01/11/2001WO2001002368A1 N-heterocyclic derivatives with neuronal activity
01/11/2001WO2001002364A1 New npy antagonists
01/11/2001WO2001002363A2 N-substituted glycine derivatives
01/11/2001WO2001002362A1 Azo amino acid derivatives for the treatment of neurological diseases
01/11/2001WO2001002361A1 Beta-amino acid derivatives for the treatment of neurological diseases
01/11/2001WO2001002359A1 Heterocyclic compounds and medicinal use thereof
01/11/2001WO2001002354A1 Phthalamide derivatives, intermediates in the production thereof, and agricultural/horticultural insecticides and method of using the same
01/11/2001WO2001002350A2 Novel amino sulfonamides and amido sulfonamides as antiviral agents
01/11/2001WO2001002349A1 Phenyl sulfamate derivatives
01/11/2001WO2001002344A1 Aminobenzoic acid derivatives
01/11/2001CA2377771A1 Heterocyclic compounds and medical use thereof
01/11/2001CA2376553A1 Aminobenzoic acid derivatives
01/10/2001EP1067109A1 Carboxylic acid derivatives and drugs containing the same as the active ingredient
01/10/2001EP1066316A1 Cinnamic acid derivatives having cell adhesion modulating activity